Femasys stock.

About Femasys. Femasys is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead ...That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...Femasys Stock Earnings. The value each FEMY share was expected to gain vs. the value that each FEMY share actually gained. Femasys ( FEMY) reported Q3 2023 earnings per share (EPS) of -$0.26, missing estimates of -$0.22 by 21.75%. In the same quarter last year, Femasys 's earnings per share (EPS) was -$0.25. Femasys is expected to release next ...Operating Status Active. Last Funding Type Post-IPO Debt. Legal Name Femasys Inc. Stock Symbol NASDAQ:FEMY. Company Type For Profit. Contact Email [email protected]. Phone Number 1 (770) 500-3910. Femasys is a biomedical company focused on transforming women’s healthcare worldwide by …Health Canada approved Femasys' ( NASDAQ: FEMY) FemaSeed, a product for localized directional insemination for infertility. The company said FemaSeed is the first-ever infertility solution aimed ...

26 sept 2023 ... Femasys investors are celebrating on Tuesday after the company got approval from for its infertility treatment. This has FEMY stock rising.ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide …Web

FEMY Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Femasys in the last 3 months. The average price target is $10.67 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 620.95% change from the last price of $1.48.

Femasys Inc. (NASDAQ: FEMY) shares were stationery Thursday, as the biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of products, announced ...Femasys Inc. FEMYNASDAQ FEMYNASDAQ 0.9138USD +0.0118 +1.31% At close at 16:59 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …WebNov 30, 2023 · ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ... Sep 27, 2023 · Femasys has a market capitalisation of US$22m and burnt through US$11m last year, which is 50% of the company's market value. ... It does not constitute a recommendation to buy or sell any stock ... About Femasys Inc · Most Popular · Stocks Rankings for FEMY · Femasys Inc Vitals · Femasys Inc Competitors - Telecommunications Equipment · Top Movers Daily change%.

Check Out Our Latest Research Report on Femasys. Femasys Stock Performance. NASDAQ:FEMY opened at $0.96 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.28 and a current ratio of 4.68. The firm’s 50-day moving average is $1.25 and its 200-day moving average is $0.81.

On June 22, 2021, Femasys Inc. (the “Company”) filed an eleventh amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the completion of the Company’s initial public offering of its common stock (the “IPO”).

Femasys Inc. Common Stock (FEMY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Femasys Inc. Common Stock (FEMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Dec 1, 2023 · Femasys Inc FEMY Morningstar Rating Unlock Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance... Femasys Inc (NASDAQ: FEMY) shares surged after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September .H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Femasys (FEMY – Research Report) today and set a price target of $5.00.The company’s shares opened today at $0.82. According to ...Femasys expects the resulting patent, when issued, will have an anticipated expiration in 2039, at the earliest. In October, Femasys regained compliance with Nasdaq’s minimum bid price requirement, after having received a notice on June 1, 2023 from Nasdaq that they were not in compliance with such requirement.

Nov. 30, 2023 5:40 PM ET Femasys Inc. (FEMY) By: Tiyashi Datta, SA News Editor. Femasys ( NASDAQ: FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an ...Nov 24, 2023 · Complete Femasys Inc. stock information by Barron's. View real-time FEMY stock price and news, along with industry-best analysis. ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the ...Femasys Inc () Stock Market info Recommendations: Buy or sell Femasys stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Femasys share forecasts, stock quote and buy / sell signals below.According to present data Femasys's FEMY shares and potentially its market environment have been in bearish …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.The stock of Femasys Inc (FEMY) has seen a -20.00% decrease in the past week, with a -27.78% drop in the past month, and a 152.43% flourish in the past quarter. The volatility ratio for the week is 12.52%, and the volatility levels for the past 30 days are at 13.78% for FEMY. The simple […]

Femasys Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 27, 2023 5:01 p.m. EST Delayed quote $ 1.0500 0.02 1.94% After Hours Volume: 21.5K Advanced Charting Volume: 842.8K... Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.

Femasys Inc. (FEMY) Stock Price, Quote, News & Analysis Breaking - Micron boosts Q1 guidance due to improved supply and demand, pricing FEMY Femasys Inc. Stock Price & Overview 657...Apr 19, 2023 · ATLANTA, April 19, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs by developing a suite of products and product candidates that include ... Femasys ( NASDAQ: FEMY ) stock price has made a strong comeback in the past few days as investors cheer the company’s FDA news. The shares surged to a high of $1.71, the highest level since October last year. They have soared by more than 320% from the lowest point this year. Femasys FDA approvalFemasys, a medical device company, is set to launch its minimally invasive reproductive health products for women in 2024. ... Its stock ran from $0.33 to an intraday high of $4.75 a few days ...Zacks Rank: FEMY currently carries a Zacks Rank #3. Femasys Inc. Price and Consensus. Femasys Inc. price-consensus-chart | Femasys Inc. Quote. Stocks to Consider. Here are some stocks in the same ...Femasys GAAP EPS of -$0.22 misses by $0.02, revenue of $0.32M misses by $0.05M SA News Thu, Aug. 10 Femsys stock jumps 21% after FDA green lights FemBloc testingThe stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.A few examples include why shares of Tharimmune (NASDAQ: THAR) and Femasys (NASDAQ: FEMY) stock are up, as well as the biggest pre-market stock movers for today. All of that info is available at ...Why Is Femasys (FEMY) Stock Up 181% Today? investorplace.com - September 26 at 9:11 AM. Femasys up 205% as FDA clears fertility treatment. seekingalpha.com - September 25 at 11:56 PM. Femasys Secures FDA 510 (k) Clearance To Market FemaSeed. markets.businessinsider.com - September 25 at 6:56 PM.

Portfolio Overview. Our non-surgical, proprietary delivery platform requires no capital equipment and leverages existing intrauterine techniques. Our minimally invasive technologies are designed to provide safe, convenient in-office approaches, saving time and reducing costs. Femasys has an expansive, internally-created intellectual property ...

Why Is Femasys (FEMY) Stock Up 181% Today? investorplace.com - September 26 at 9:11 AM. Femasys up 205% as FDA clears fertility treatment. seekingalpha.com - September 25 at 11:56 PM. Femasys Secures FDA 510 (k) Clearance To Market FemaSeed. markets.businessinsider.com - September 25 at 6:56 PM.

Femasys Inc. Common Stock (FEMY) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price that an... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Femasys share forecasts, stock quote and buy / sell signals below. According to present data Femasys's FEMY shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Shares Outstanding 21.65 M Public Float 19.48 M Yield FEMY is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) …WebDec 1, 2023 · Stock analysis for Femasys Inc (FEMY:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CI. Earnings Flash (FEMY) FEMASYS Reports Q3 Revenue $86,186. Nov. 14. MT. Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc. Nov. 13. CI. Femasys Inc. Successfully Completes the Stage 2 European Union (EU) Medical Device Regulation. Oct. 26.Finally, UBS Group AG grew its holdings in Femasys by 6,394.8% during the first quarter. UBS Group AG now owns 66,702 shares of the company’s stock valued at $151,000 after purchasing an additional 65,675 shares during the period. Institutional investors and hedge funds own 8.29% of the company’s stock. About Femasys (Get …Check Out Our Latest Research Report on Femasys. Femasys Stock Performance. NASDAQ:FEMY opened at $0.96 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.28 and a current ratio of 4.68. The firm’s 50-day moving average is $1.25 and its 200-day moving average is $0.81.Get Femasys Inc (FEMY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsGainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.Femasys Inc. (NASDAQ: FEMY) shares were stationery Thursday, as the biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of products, announced ...Femasys Inc. (FEMY) Stock Price, Quote, News & Analysis Breaking - Micron boosts Q1 guidance due to improved supply and demand, pricing FEMY Femasys Inc. Stock Price & Overview 657...

May 26, 2023 · At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. Femasys Inc Follow Share $1.03 After Hours: $1.06 (2.91%) +0.030 Closed: Nov 24, 4:59:11 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Soleno Therapeutics Inc $28.87 SLNO3.11% Novo... 0.13% QQQ 389.08 0.11% SPIKE – 3.39% BTC/USD 37034.02 0.9542% DIA 353.48 0.09% 187.02 0.81% TLT 91.10 1.45% Femasys Inc (NASDAQ:FEMY) $1.04 …WebInstagram:https://instagram. best future trading brokerelderly care in home costsleast expensive way to buy goldvmfxx interest rate Check Out Our Latest Research Report on Femasys. Femasys Stock Performance. NASDAQ:FEMY opened at $0.96 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.28 and a current ratio of 4.68. The firm’s 50-day moving average is $1.25 and its 200-day moving average is $0.81.PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (Femasys), a biomedical company focused on meeting... Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update Globe Newswire • … team stock forecastogiax Femasys' (FEMY) revenues in third-quarter 2023 are expected to have been driven by the higher international sales of its marketed products. ... Femasys Inc. Quote. Stocks to Consider. bee stock Dec 1, 2023 · The Femasys Inc. stock price fell by -3.27% on the last day (Wednesday, 29th Nov 2023) from $1.01 to $0.98. During the last trading day the stock fluctuated 6.91% from a day low at $0.96 to a day high of $1.03. The price has fallen in 5 of the last 10 days but is still up by 5.05% over the past 2 weeks. Nov 30, 2023 · ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...